[HTML][HTML] Concomitant tricuspid repair in patients with degenerative mitral regurgitation
JS Gammie, MWA Chu, V Falk… - … England Journal of …, 2022 - Mass Medical Soc
Background Tricuspid regurgitation is common in patients with severe degenerative mitral
regurgitation. However, the evidence base is insufficient to inform a decision about whether …
regurgitation. However, the evidence base is insufficient to inform a decision about whether …
Multi-modality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper
P Lancellotti, P Pibarot, J Chambers… - European Heart …, 2022 - academic.oup.com
Valvular regurgitation represents an important cause of cardiovascular morbidity and
mortality. Imaging is pivotal in the evaluation of native valve regurgitation and …
mortality. Imaging is pivotal in the evaluation of native valve regurgitation and …
[HTML][HTML] Transcatheter treatment for tricuspid valve disease: Transcatheter treatment for tricuspid valve disease
Approximately 4% of subjects aged 75 years or more have clinically relevant tricuspid
regurgitation (TR). Primary TR results from anatomical abnormality of the tricuspid valve …
regurgitation (TR). Primary TR results from anatomical abnormality of the tricuspid valve …
PCI in patients undergoing transcatheter aortic-valve implantation
Background The benefit of percutaneous coronary intervention (PCI) in patients with stable
coronary artery disease and severe aortic stenosis who are undergoing transcatheter aortic …
coronary artery disease and severe aortic stenosis who are undergoing transcatheter aortic …
Transcatheter or surgical treatment of aortic-valve stenosis
S Blankenberg, M Seiffert, R Vonthein… - … England Journal of …, 2024 - Mass Medical Soc
Background Among low-risk patients with severe, symptomatic aortic stenosis who are
eligible for both transcatheter aortic-valve implantation (TAVI) and surgical aortic-valve …
eligible for both transcatheter aortic-valve implantation (TAVI) and surgical aortic-valve …
Transcatheter repair versus mitral-valve surgery for secondary mitral regurgitation
Background Current treatment recommendations for patients with heart failure and
secondary mitral regurgitation include transcatheter edge-to-edge repair and mitral-valve …
secondary mitral regurgitation include transcatheter edge-to-edge repair and mitral-valve …
TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery
Aims Isolated tricuspid valve surgery (ITVS) is considered to be a high-risk procedure, but in-
hospital mortality is markedly variable. This study sought to develop a dedicated risk score …
hospital mortality is markedly variable. This study sought to develop a dedicated risk score …
EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart …
A Sabbag, B Essayagh, JDR Barrera, C Basso… - Europace, 2022 - academic.oup.com
Risk stratification scheme. Risk stratification aiming at assessing the risk of VAs and SCD in
patients with MVP, involving two phases based on the clinical and imaging context and the …
patients with MVP, involving two phases based on the clinical and imaging context and the …
Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial
Aims The respective roles of oral anticoagulation or antiplatelet therapy following
transcatheter aortic valve implantation (TAVI) remain debated. ATLANTIS is an international …
transcatheter aortic valve implantation (TAVI) remain debated. ATLANTIS is an international …